Scott Huntington MD MPH, MSHP

Hematologic Oncology

Associate Professor of Medicine (Section of Hematology)

333 Cedar StNew Haven, CT 06510
Phone+1 203-200-4363
Fax+1 203-200-6385

Dr. Huntington is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Huntington's full profile Already have an account?

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2012 - 2015
Vanderbilt University Medical CenterResidency, Internal Medicine, 2009 - 2012
Icahn School of Medicine at Mount SinaiClass of 2009

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CT State Medical License 2015 - 2027
PA State Medical License 2012 - 2016
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016

Publications & Presentations

PubMed

Treatment inequity among older adults with newly diagnosed acute myeloid leukemia ineligible for intensive therapy.
Alain Mina, Yanqing Xu, Tatyana A Kapustyan, Mazaher Dhalla, Cheng Chen
Leukemia & Lymphoma. 2026-07-12
Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia.
Satoko Ito, Kunal C Potnis, Ding Quan Ng, Kishan K Patel, Manraj Sra
Blood. Red Cells & Iron. 2026-06-01
4 citations
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.
William G Wierda, Jennifer Brown, Jeremy S Abramson, Farrukh Awan, Greg Bociek
Journal of the National Comprehensive Cancer Network. 2026-03-01

Abstracts/Posters

Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience
Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neopl...
Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Peripheral Blood Involvement By Flow Cytometry As a Prognostic Factor in Aggressive T Cell Lymphomas Following Autologous Stem Cell Transplantation
Scott F. Huntington, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Hodgkin Lymphoma: Celebrating 200 Years Since Thomas Hodgkin Entered Medicine
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Cost-effectiveness analysis of brentuximab vedotin with chemotherapy in newly diagnosed stage III/IV Hodgkin lymphoma.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

Broadstep Acquires Bethesda Residential and Support Programs in Illinois, Indiana, WisconsinJune 22nd, 2021
Student Research Day Celebrates Students and MentorsJune 1st, 2021
Yale Cancer Center Investigators Show Recommended, but Underused Treatment for Rare Blood Cancer Saves LivesNovember 5th, 2018